RA Capital Management - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 68 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 38.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2013$7,076,000
-16.4%
763,332
-11.6%
0.74%
-34.1%
Q2 2013$8,461,000863,3321.12%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q4 2013
NameSharesValueWeighting ↓
Abingworth LLP 396,104$400,0000.42%
Ancora Advisors LLC 50,865$51,0000.01%
EAGLE GLOBAL ADVISORS LLC 145,710$146,0000.00%
Acrospire Investment Management LLC 5,200$5,0000.00%
A.R.T. Advisors, LLC 57,954$57,0000.00%
Renaissance Technologies 876,100$876,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 4,600$5,0000.00%
Cutler Group LLC / CA 11,048$11,0000.00%
PANAGORA ASSET MANAGEMENT INC 133,846$134,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$46,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders